1
|
Vásquez V, Orozco J. Detection of COVID-19-related biomarkers by electrochemical biosensors and potential for diagnosis, prognosis, and prediction of the course of the disease in the context of personalized medicine. Anal Bioanal Chem 2023; 415:1003-1031. [PMID: 35970970 PMCID: PMC9378265 DOI: 10.1007/s00216-022-04237-7] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2022] [Revised: 06/30/2022] [Accepted: 07/18/2022] [Indexed: 02/07/2023]
Abstract
As a more efficient and effective way to address disease diagnosis and intervention, cutting-edge technologies, devices, therapeutic approaches, and practices have emerged within the personalized medicine concept depending on the particular patient's biology and the molecular basis of the disease. Personalized medicine is expected to play a pivotal role in assessing disease risk or predicting response to treatment, understanding a person's health status, and, therefore, health care decision-making. This work discusses electrochemical biosensors for monitoring multiparametric biomarkers at different molecular levels and their potential to elucidate the health status of an individual in a personalized manner. In particular, and as an illustration, we discuss several aspects of the infection produced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a current health care concern worldwide. This includes SARS-CoV-2 structure, mechanism of infection, biomarkers, and electrochemical biosensors most commonly explored for diagnostics, prognostics, and potentially assessing the risk of complications in patients in the context of personalized medicine. Finally, some concluding remarks and perspectives hint at the use of electrochemical biosensors in the frame of other cutting-edge converging/emerging technologies toward the inauguration of a new paradigm of personalized medicine.
Collapse
Affiliation(s)
- Viviana Vásquez
- Max Planck Tandem Group in Nanobioengineering, Institute of Chemistry, Faculty of Natural and Exact Sciences, University of Antioquia, Complejo Ruta N, Calle 67 N° 52-20, Medellín, 050010, Colombia
| | - Jahir Orozco
- Max Planck Tandem Group in Nanobioengineering, Institute of Chemistry, Faculty of Natural and Exact Sciences, University of Antioquia, Complejo Ruta N, Calle 67 N° 52-20, Medellín, 050010, Colombia.
| |
Collapse
|
2
|
Song H, Shin H, Seo H, Park W, Joo BJ, Kim J, Kim J, Kim HK, Kim J, Park J. Wireless Non-Invasive Monitoring of Cholesterol Using a Smart Contact Lens. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2022; 9:e2203597. [PMID: 35975449 PMCID: PMC9534953 DOI: 10.1002/advs.202203597] [Citation(s) in RCA: 19] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 06/21/2022] [Revised: 08/02/2022] [Indexed: 06/15/2023]
Abstract
Herein, a wireless and soft smart contact lens that enables real-time quantitative recording of cholesterol in tear fluids for the monitoring of patients with hyperlipidemia using a smartphone is reported. This contact lens incorporates an electrochemical biosensor for the continuous detection of cholesterol concentrations, stretchable antenna, and integrated circuits for wireless communication, which makes a smartphone the only device required to operate this lens remotely without obstructing the wearer's vision. The hyperlipidemia rabbit model is utilized to confirm the correlation between cholesterol levels in tear fluid and blood and to confirm the feasibility of this smart contact lens for diagnostic application of cholesterol-related diseases. Further in vivo tests with human subjects demonstrated its good biocompatibility, wearability, and reliability as a non-invasive healthcare device.
Collapse
Affiliation(s)
- Hayoung Song
- Department of Materials Science and EngineeringCenter for Nanomedicine Institute for Basic Science (IBS)Yonsei UniversitySeoul03722Republic of Korea
| | - Haein Shin
- Department of Materials Science and EngineeringCenter for Nanomedicine Institute for Basic Science (IBS)Yonsei UniversitySeoul03722Republic of Korea
| | - Hunkyu Seo
- Department of Materials Science and EngineeringCenter for Nanomedicine Institute for Basic Science (IBS)Yonsei UniversitySeoul03722Republic of Korea
| | - Wonjung Park
- Department of Materials Science and EngineeringCenter for Nanomedicine Institute for Basic Science (IBS)Yonsei UniversitySeoul03722Republic of Korea
| | - Byung Jun Joo
- Department of Materials Science and EngineeringCenter for Nanomedicine Institute for Basic Science (IBS)Yonsei UniversitySeoul03722Republic of Korea
| | - Jeongho Kim
- Department of Biomedical ScienceThe Graduate SchoolKyungpook National University680 Gukchebosang‐ro, Jung‐guDaegu41944Republic of Korea
| | - Jeonghyun Kim
- Department of Electronics Convergence EngineeringKwangwoon UniversitySeoul01897Republic of Korea
| | - Hong Kyun Kim
- Department of Biomedical ScienceThe Graduate SchoolKyungpook National University680 Gukchebosang‐ro, Jung‐guDaegu41944Republic of Korea
- Department of OphthalmologyBio‐Medical InstituteSchool of MedicineKyungpook National University Hospital130 Dongdeok‐ro, Jung‐guDaegu41944Republic of Korea
| | - Jayoung Kim
- Department of Medical EngineeringCollege of MedicineYonsei UniversitySeoul03722Republic of Korea
| | - Jang‐Ung Park
- Department of Materials Science and EngineeringCenter for Nanomedicine Institute for Basic Science (IBS)Yonsei UniversitySeoul03722Republic of Korea
- KIURI InstituteYonsei UniversitySeoul03722Republic of Korea
| |
Collapse
|
3
|
Singh SU, Chatterjee S, Lone SA, Ho HH, Kaswan K, Peringeth K, Khan A, Chiang YW, Lee S, Lin ZH. Advanced wearable biosensors for the detection of body fluids and exhaled breath by graphene. Mikrochim Acta 2022; 189:236. [PMID: 35633385 PMCID: PMC9146825 DOI: 10.1007/s00604-022-05317-2] [Citation(s) in RCA: 19] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/25/2021] [Accepted: 04/22/2022] [Indexed: 11/02/2022]
Abstract
Given the huge economic burden caused by chronic and acute diseases on human beings, it is an urgent requirement of a cost-effective diagnosis and monitoring process to treat and cure the disease in their preliminary stage to avoid severe complications. Wearable biosensors have been developed by using numerous materials for non-invasive, wireless, and consistent human health monitoring. Graphene, a 2D nanomaterial, has received considerable attention for the development of wearable biosensors due to its outstanding physical, chemical, and structural properties. Moreover, the extremely flexible, foldable, and biocompatible nature of graphene provide a wide scope for developing wearable biosensor devices. Therefore, graphene and its derivatives could be trending materials to fabricate wearable biosensor devices for remote human health management in the near future. Various biofluids and exhaled breath contain many relevant biomarkers which can be exploited by wearable biosensors non-invasively to identify diseases. In this article, we have discussed various methodologies and strategies for synthesizing and pattering graphene. Furthermore, general sensing mechanism of biosensors, and graphene-based biosensing devices for tear, sweat, interstitial fluid (ISF), saliva, and exhaled breath have also been explored and discussed thoroughly. Finally, current challenges and future prospective of graphene-based wearable biosensors have been evaluated with conclusion. Graphene is a promising 2D material for the development of wearable sensors. Various biofluids (sweat, tears, saliva and ISF) and exhaled breath contains many relevant biomarkers which facilitate in identify diseases. Biosensor is made up of biological recognition element such as enzyme, antibody, nucleic acid, hormone, organelle, or complete cell and physical (transducer, amplifier), provide fast response without causing organ harm.
Collapse
Affiliation(s)
- Santoshi U Singh
- Department of Chemistry, National Tsing Hua University, Hsinchu, 30013, Taiwan
- Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu, 30013, Taiwan
| | - Subhodeep Chatterjee
- Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu, 30013, Taiwan
- Department of Power and Mechanical Engineering, National Tsing Hua University, Hsinchu, 30013, Taiwan
| | - Shahbaz Ahmad Lone
- Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu, 30013, Taiwan
| | - Hsin-Hsuan Ho
- Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu, 30013, Taiwan
| | - Kuldeep Kaswan
- Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu, 30013, Taiwan
| | - Kiran Peringeth
- Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu, 30013, Taiwan
- Department of Power and Mechanical Engineering, National Tsing Hua University, Hsinchu, 30013, Taiwan
| | - Arshad Khan
- Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu, 30013, Taiwan
| | - Yun-Wei Chiang
- Department of Chemistry, National Tsing Hua University, Hsinchu, 30013, Taiwan
| | - Sangmin Lee
- School of Mechanical Engineering, Chung-Ang University, Seoul, 06974, South Korea.
| | - Zong-Hong Lin
- Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu, 30013, Taiwan.
- Department of Power and Mechanical Engineering, National Tsing Hua University, Hsinchu, 30013, Taiwan.
- Frontier Research Center On Fundamental and Applied Sciences of Matters, National Tsing Hua University, Hsinchu, 30013, Taiwan.
| |
Collapse
|
4
|
Gulias-Cañizo R, Ruíz-Leyja ED, Sánchez-Huerta V, Ochoa-de la Paz L. SARS-CoV-2 and the Eye: A Relationship for a Possible Prognostic Tool in COVID-19 Patients. Clin Ophthalmol 2021; 15:707-712. [PMID: 33658751 PMCID: PMC7917349 DOI: 10.2147/opth.s284191] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2020] [Accepted: 12/04/2020] [Indexed: 01/08/2023] Open
Abstract
PURPOSE In December 2019 there was the first report about a new viral infection in Wuhan, China. The new virus was taxonomically designed as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causing the coronavirus disease 2019 (COVID-19). SARS-CoV-2 uses the angiotensin-converting enzyme 2 (ACE2) receptor for cell invasion, which is expressed in different tissues including lungs, small intestine, testicles, kidneys, brain, and the eye. The purpose of this article is to review the available information on the relationship of COVID-19 with the eye, as well as evaluating the possible usefulness of ocular diagnostic tests to help in the diagnosis and/or monitoring of patients with this disease. METHODS We performed a retrospective review of relevant articles from November 2019 to April 2020. RESULTS Ocular infection by SARS-CoV-2 is still controversial; nevertheless, the possibility of being a viral reservoir has been suggested, increasing the likelihood of infection. Some reports demonstrated the presence of SARS-CoV-2 in tears, and previously published data suggest a pathological increase of cytokine concentrations in COVID-19 patients; the cytokine release syndrome or cytokine storm contributes to lung and central nervous system damage. The usefulness of tears for the measurement of inflammatory cytokines in various diseases is well known, in particular IL-6, which has been correlated to the severity of COVID-19. CONCLUSION Considering that the IL-6 signaling cascade may be activated in patients with COVID-19, makes it an excellent target for diagnostic and/or monitoring purposes.
Collapse
Affiliation(s)
- Rosario Gulias-Cañizo
- Facultad de Ciencias de la Salud, Universidad Anáhuac México, Huixquilucan, Edo. de México, México
| | - Estela D’Abril Ruíz-Leyja
- Asociación Para Evitar la Ceguera en México I.A.P. Hospital Dr. Luis Sánchez Bulnes, Mexico City, 04020, Mexico
| | - Valeria Sánchez-Huerta
- Asociación Para Evitar la Ceguera en México I.A.P. Hospital Dr. Luis Sánchez Bulnes, Mexico City, 04020, Mexico
| | - Lenin Ochoa-de la Paz
- Asociación Para Evitar la Ceguera en México I.A.P. Hospital Dr. Luis Sánchez Bulnes, Mexico City, 04020, Mexico
- Departamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, 04510, Mexico
| |
Collapse
|
5
|
Woodward AM, Senchyna M, Argüeso P. Short-Term Reproducibility of MUC5AC Measurement in Human Tear Fluid. Diagnostics (Basel) 2021; 11:diagnostics11010057. [PMID: 33401679 PMCID: PMC7824712 DOI: 10.3390/diagnostics11010057] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2020] [Revised: 12/29/2020] [Accepted: 12/31/2020] [Indexed: 01/13/2023] Open
Abstract
The assessment of tear fluid components is a common and valuable approach to understanding ocular surface disease and testing the efficacy of novel therapeutic strategies. However, the interpretation and utility of the findings can be limited by changes in the composition of the tear film, particularly in studies requiring repetitive patient sampling. Here, tear samples were collected twice within a one-hour interval to evaluate the short-term reproducibility of an immunoassay aimed to measure the amount of MUC5AC mucin. We found no statistical difference in total protein or MUC5AC content between the two consecutive collections of tear fluid, although the inter-individual variability in each group was high, with coefficients of variation exceeding 30% and 50%, respectively. Scatterplots showed a significant correlation in both protein and MUC5AC following collection within a one-hour interval. These data indicate that, regardless of the high inter-individual variability, repeated collection of tear fluid within an hour interval produces reproducible intra-individual data in terms of MUC5AC mucin content, and suggest that the normal mucin composition of the tear fluid can be re-established within an hour of the initial collection.
Collapse
Affiliation(s)
- Ashley M. Woodward
- Department of Ophthalmology, Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, MA 02114, USA;
| | | | - Pablo Argüeso
- Department of Ophthalmology, Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, MA 02114, USA;
- Correspondence: ; Tel.: +1-617-912-0249
| |
Collapse
|
6
|
Li S, Zhou J, Bu J, Ning K, Zhang L, Li J, Guo Y, He X, He H, Cai X, Chen Y, Reinach PS, Liu Z, Li W. Ectodysplasin A protein promotes corneal epithelial cell proliferation. J Biol Chem 2017; 292:13391-13401. [PMID: 28655773 DOI: 10.1074/jbc.m117.803809] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2017] [Indexed: 11/06/2022] Open
Abstract
The EDA gene encodes ectodysplasin A (Eda), which if mutated causes X-linked hypohidrotic ectodermal dysplasia (XLHED) disease in humans. Ocular surface changes occur in XLHED patients whereas its underlying mechanism remains elusive. In this study, we found Eda was highly expressed in meibomian glands, and it was detected in human tears but not serum. Corneal epithelial integrity was defective and the thickness was reduced in the early postnatal stage of Eda mutant Tabby mice. Corneal epithelial cell proliferation decreased and the epithelial wound healing was delayed in Tabby mice, whereas it was restored by exogenous Eda. Eda exposure promoted mouse corneal epithelial wound healing during organ culture, whereas scratch wound assay showed that it did not affect human corneal epithelial cell line migration. Epidermal growth factor receptor (EGFR), phosphorylated EGFR (p-EGFR), and phosphorylated ERK1/2 (p-ERK) were down-regulated in Tabby mice corneal epithelium. Eda treatment up-regulated the expression of Ki67, EGFR, p-EGFR, and p-ERK in human corneal epithelial cells in a dose-dependent manner. In conclusion, Eda protein can be secreted from meibomian glands and promotes corneal epithelial cell proliferation through regulation of the EGFR signaling pathway. Eda release into the tears plays an essential role in the maintenance of corneal epithelial homeostasis.
Collapse
Affiliation(s)
- Sanming Li
- From the Eye Institute of Xiamen University, Xiamen, Fujian 361102.,the Medical College of Xiamen University, Xiamen, Fujian 361102.,the Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen, Fujian 361102, and
| | - Jing Zhou
- From the Eye Institute of Xiamen University, Xiamen, Fujian 361102.,the Medical College of Xiamen University, Xiamen, Fujian 361102.,the Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen, Fujian 361102, and
| | - Jinghua Bu
- From the Eye Institute of Xiamen University, Xiamen, Fujian 361102.,the Medical College of Xiamen University, Xiamen, Fujian 361102.,the Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen, Fujian 361102, and
| | - Ke Ning
- From the Eye Institute of Xiamen University, Xiamen, Fujian 361102.,the Medical College of Xiamen University, Xiamen, Fujian 361102.,the Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen, Fujian 361102, and
| | - Liying Zhang
- From the Eye Institute of Xiamen University, Xiamen, Fujian 361102.,the Medical College of Xiamen University, Xiamen, Fujian 361102.,the Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen, Fujian 361102, and
| | - Juan Li
- From the Eye Institute of Xiamen University, Xiamen, Fujian 361102.,the Medical College of Xiamen University, Xiamen, Fujian 361102.,the Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen, Fujian 361102, and
| | - Yuli Guo
- From the Eye Institute of Xiamen University, Xiamen, Fujian 361102.,the Medical College of Xiamen University, Xiamen, Fujian 361102.,the Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen, Fujian 361102, and
| | - Xin He
- From the Eye Institute of Xiamen University, Xiamen, Fujian 361102.,the Medical College of Xiamen University, Xiamen, Fujian 361102.,the Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen, Fujian 361102, and
| | - Hui He
- From the Eye Institute of Xiamen University, Xiamen, Fujian 361102.,the Medical College of Xiamen University, Xiamen, Fujian 361102.,the Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen, Fujian 361102, and
| | - Xiaoxin Cai
- From the Eye Institute of Xiamen University, Xiamen, Fujian 361102.,the Medical College of Xiamen University, Xiamen, Fujian 361102.,the Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen, Fujian 361102, and
| | - Yongxiong Chen
- From the Eye Institute of Xiamen University, Xiamen, Fujian 361102.,the Medical College of Xiamen University, Xiamen, Fujian 361102.,the Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen, Fujian 361102, and
| | | | - Zuguo Liu
- From the Eye Institute of Xiamen University, Xiamen, Fujian 361102.,the Medical College of Xiamen University, Xiamen, Fujian 361102.,the Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen, Fujian 361102, and.,the Xiamen University affiliated Xiamen Eye Center, Xiamen, Fujian 361000
| | - Wei Li
- From the Eye Institute of Xiamen University, Xiamen, Fujian 361102, .,the Medical College of Xiamen University, Xiamen, Fujian 361102.,the Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen, Fujian 361102, and.,the Xiamen University affiliated Xiamen Eye Center, Xiamen, Fujian 361000
| |
Collapse
|
7
|
Dutkiewicz EP, Urban PL. Quantitative mass spectrometry of unconventional human biological matrices. PHILOSOPHICAL TRANSACTIONS. SERIES A, MATHEMATICAL, PHYSICAL, AND ENGINEERING SCIENCES 2016; 374:20150380. [PMID: 27644966 PMCID: PMC5031645 DOI: 10.1098/rsta.2015.0380] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 06/02/2016] [Indexed: 06/06/2023]
Abstract
The development of sensitive and versatile mass spectrometric methodology has fuelled interest in the analysis of metabolites and drugs in unconventional biological specimens. Here, we discuss the analysis of eight human matrices-hair, nail, breath, saliva, tears, meibum, nasal mucus and skin excretions (including sweat)-by mass spectrometry (MS). The use of such specimens brings a number of advantages, the most important being non-invasive sampling, the limited risk of adulteration and the ability to obtain information that complements blood and urine tests. The most often studied matrices are hair, breath and saliva. This review primarily focuses on endogenous (e.g. potential biomarkers, hormones) and exogenous (e.g. drugs, environmental contaminants) small molecules. The majority of analytical methods used chromatographic separation prior to MS; however, such a hyphenated methodology greatly limits analytical throughput. On the other hand, the mass spectrometric methods that exclude chromatographic separation are fast but suffer from matrix interferences. To enable development of quantitative assays for unconventional matrices, it is desirable to standardize the protocols for the analysis of each specimen and create appropriate certified reference materials. Overcoming these challenges will make analysis of unconventional human biological matrices more common in a clinical setting.This article is part of the themed issue 'Quantitative mass spectrometry'.
Collapse
Affiliation(s)
- Ewelina P Dutkiewicz
- Department of Applied Chemistry, National Chiao Tung University, 1001 University Rd, Hsinchu 300, Taiwan
| | - Pawel L Urban
- Department of Applied Chemistry, National Chiao Tung University, 1001 University Rd, Hsinchu 300, Taiwan Institute of Molecular Science, National Chiao Tung University, 1001 University Rd, Hsinchu 300, Taiwan
| |
Collapse
|
8
|
Kim JS, Lee H, Choi S, Kim EK, Seo KY, Kim TI. Assessment of the Tear Film Lipid Layer Thickness after Cataract Surgery. Semin Ophthalmol 2016; 33:231-236. [PMID: 27627886 DOI: 10.1080/08820538.2016.1208764] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Abstract
PURPOSE To evaluate changes in the tear film lipid layer thickness (LLT) after cataract surgery and the effects of cataract surgery on dry eye syndrome (DES) and meibomian gland dysfunction (MGD). METHODS LLT measurements obtained using the LipiView interferometer, tear break-up time (TBUT) measurements, Schirmer's tests, Oxford staining scores, lid margin and meibomian gland findings, and the Ocular Surface Disease Index (OSDI) questionnaire scores were evaluated before and one and three months after cataract surgery. RESULTS Forty-three eyes (43 patients) were included. LLT was significantly thinner one month after surgery than at baseline (P = 0.004). TBUT was significantly shorter at both one (P < 0.001) and three (P < 0.001) months after surgery than at baseline. OSDI scores were significantly higher (P < 0.001) and the meibum quality was significantly poorer (P = 0.001) at one month after surgery than at baseline. TBUT was significantly and positively correlated with LLT (r = 0.29, P < 0.001), while the OSDI (r = -0.38, P < 0.001) and Oxford staining (r = -0.30, P = 0.001) scores and the meibum quality (r = -0.21, P = 0.01) were significantly and negatively correlated with LLT. CONCLUSIONS The tear film LLT was significantly thinner and DES and MGD parameters showed deterioration after cataract surgery. In addition, LLT was significantly correlated with DES and MGD parameters. These results suggest that clinicians should consider the tear film lipid layer while managing the exacerbation of DES after cataract surgery.
Collapse
Affiliation(s)
- Jin Sun Kim
- a Department of Ophthalmology , The Institute of Vision Research, Yonsei University College of Medicine , Seoul , South Korea
| | - Hun Lee
- a Department of Ophthalmology , The Institute of Vision Research, Yonsei University College of Medicine , Seoul , South Korea.,b Department of Ophthalmology , International St. Mary's Hospital, Catholic Kwandong University College of Medicine , Incheon , South Korea
| | - Seonghee Choi
- a Department of Ophthalmology , The Institute of Vision Research, Yonsei University College of Medicine , Seoul , South Korea
| | - Eung Kweon Kim
- a Department of Ophthalmology , The Institute of Vision Research, Yonsei University College of Medicine , Seoul , South Korea.,c Department of Ophthalmology, Corneal Dystrophy Research Institute , Yonsei University College of Medicine , Seoul , South Korea
| | - Kyoung Yul Seo
- a Department of Ophthalmology , The Institute of Vision Research, Yonsei University College of Medicine , Seoul , South Korea
| | - Tae-Im Kim
- a Department of Ophthalmology , The Institute of Vision Research, Yonsei University College of Medicine , Seoul , South Korea
| |
Collapse
|
9
|
Improving Diagnosis and Outcomes of Sjögren's Disease through Targeting Dry Eye Patients: A Continuing Medical Education Enduring Material. Ocul Surf 2015. [DOI: 10.1016/j.jtos.2015.08.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
10
|
Farandos NM, Yetisen AK, Monteiro MJ, Lowe CR, Yun SH. Contact lens sensors in ocular diagnostics. Adv Healthc Mater 2015; 4:792-810. [PMID: 25400274 DOI: 10.1002/adhm.201400504] [Citation(s) in RCA: 218] [Impact Index Per Article: 24.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2014] [Revised: 09/23/2014] [Indexed: 01/15/2023]
Abstract
Contact lenses as a minimally invasive platform for diagnostics and drug delivery have emerged in recent years. Contact lens sensors have been developed for analyzing the glucose composition of tears as a surrogate for blood glucose monitoring and for the diagnosis of glaucoma by measuring intraocular pressure. However, the eye offers a wider diagnostic potential as a sensing site and therefore contact lens sensors have the potential to improve the diagnosis and treatment of many diseases and conditions. With advances in polymer synthesis, electronics and micro/nanofabrication, contact lens sensors can be produced to quantify the concentrations of many biomolecules in ocular fluids. Non- or minimally invasive contact lens sensors can be used directly in a clinical or point-of-care setting to monitor a disease state continuously. This article reviews the state-of-the-art in contact lens sensor fabrication, their detection, wireless powering, and readout mechanisms, and integration with mobile devices and smartphones. High-volume manufacturing considerations of contact lenses are also covered and a case study of an intraocular pressure contact lens sensor is provided as an example of a successful product. This Review further analyzes the contact lens market and the FDA regulatory requirements for commercialization of contact lens sensors.
Collapse
Affiliation(s)
- Nicholas M. Farandos
- Department of Chemical Engineering; Imperial College London; South Kensington Campus London SW7 2AZ UK
| | - Ali K. Yetisen
- Department of Chemical Engineering and Biotechnology; University of Cambridge; Tennis Court Road Cambridge CB2 1QT UK
| | - Michael J. Monteiro
- Australian Institute for Bioengineering and Nanotechnology; University of Queensland; Brisbane QLD 4072 Australia
| | - Christopher R. Lowe
- Department of Chemical Engineering and Biotechnology; University of Cambridge; Tennis Court Road Cambridge CB2 1QT UK
| | - Seok Hyun Yun
- Harvard Medical School and Wellman Center for Photomedicine; Massachusetts General Hospital; 50 Blossom Street Boston MA 02114 USA
| |
Collapse
|
11
|
D’Souza S, Tong L. Practical issues concerning tear protein assays in dry eye. EYE AND VISION (LONDON, ENGLAND) 2014; 1:6. [PMID: 26605353 PMCID: PMC4604107 DOI: 10.1186/s40662-014-0006-y] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 06/28/2014] [Accepted: 10/09/2014] [Indexed: 12/20/2022]
Abstract
Dry eye is a common clinical condition diagnosed by cumulative evidence of symptoms and signs. Many new treatments in dry eye are either expensive, invasive, have potential for side effects, or are not easily accessible. In severe dry eye, the ideal modality of treatment to begin with is often not clear as specific molecular disturbances are not evident from just examination of clinical manifestations. Assessing the effects of ongoing treatment is not straight forward since there is lack of agreement between clinical signs and symptoms. There is a need to have more objective methods of selecting treatment for dry eye and monitoring the effect of treatment. Recently, there are many new technologies applied to the discovery of tear biomarkers, for e.g., mass spectrometry based proteomics techniques and multiplex assays such as the bead-based sandwich indirect immunofluorescent assays. Tear proteins assays have even been made available as point-of-care devices. This review focuses on the evidence for the involvements of tear proteins in dry eye, possible changes in tear concentrations with therapy and the strength of evidence regarding dry eye pathology. Much remains to be done in terms of developing office-based assays and ascertaining their reliability, but current evidence suggests that tear proteins have a role in the clinical practice of dry eye.
Collapse
Affiliation(s)
- Sharon D’Souza
- />Narayana Nethralaya Superspeciality Eye Hospital and Post Graduate Institute, Bangalore, Karnataka India
| | - Louis Tong
- />Singapore Eye Research Institute, 11, Third Hospital Avenue, Singapore, 168751 Singapore
- />Singapore National Eye Center, Singapore, Singapore
- />Duke-NUS Graduate Medical School, Singapore, Singapore
- />Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
| |
Collapse
|
12
|
New testing options for diagnosing and grading dry eye disease. Am J Ophthalmol 2014; 157:1122-9. [PMID: 24631478 DOI: 10.1016/j.ajo.2014.03.002] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2013] [Revised: 03/01/2014] [Accepted: 03/03/2014] [Indexed: 11/22/2022]
Abstract
PURPOSE To describe new options for diagnosis and severity grading of dry eye disease. DESIGN Perspective on technological advancements to identify tear dysfunction and their value in diagnosing and grading dry eye disease. METHODS Evidence is presented on new and evolving technologies to measure tear stability, composition, and meniscus height and their role in dry eye diagnosis and therapeutic efficacy grading is assessed. RESULTS Evolving concepts regarding pathogenesis and new technologies to evaluate the tears and ocular surface have improved the ability to diagnose, classify, and grade the severity of dry eye disease. New technologies include noninvasive imaging of tear stability and tear meniscus height as a measure of tear volume and tear composition (osmolarity, lacrimal factors, inflammatory mediators, growth and differentiation factors). Approved tests, such as tear osmolarity and tear imaging, are being integrated into clinical practice and may eventually supplant certain traditional tests that have greater variability and less sensitivity. Other tests, such as molecular assays of tears and conjunctival cells, are currently being used in studies investigating pathogenesis and therapeutic mechanism of action. They may eventually translate to routine clinical practice. CONCLUSIONS New technologies have emerged that can noninvasively evaluate the tears and measure disease-associated compositional changes. These tests are being integrated into clinical practice and therapeutic trials for diagnosis, classification, and severity grading of dry eye disease.
Collapse
|
13
|
Srinivasan S, Thangavelu M, Zhang L, Green KB, Nichols KK. iTRAQ quantitative proteomics in the analysis of tears in dry eye patients. Invest Ophthalmol Vis Sci 2012; 53:5052-9. [PMID: 22736608 DOI: 10.1167/iovs.11-9022] [Citation(s) in RCA: 97] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
PURPOSE We analyzed the change in protein expression of tear film proteins in dry eye (DE) and non-DE (NDE) patients using isobaric tag for relative and absolute quantitation (iTRAQ) technology. METHODS We categorized 24 participants into NDE, and mild (MDE), moderate-to-severe (MSDE), and mixed (MXDE) DE on the basis of clinical DE tests. Tear samples (n = 6 subjects/group) were collected using Schirmer's strips. Proteins were extracted from strips and were quantified using the Bradford assay. Protein from each sample was pooled as internal standard (IS), and 20 μg protein from each sample and the IS were digested and labeled with different tandem mass tag (TMT) isobaric mass tag labeling reagent. The reaction was quenched and the labeled peptides were mixed. Samples were injected for liquid chromatography-mass spectrometry (LC/MS/MS) analysis on the Orbitrap mass spectrometer. Bioinformatic analyses were performed using protein information resource (PIR). RESULTS Combined results showed a total of 386 proteins in tears as determined by the iTRAQ experiments. An average of 163 proteins was detected in each of 6 biologic replicates. Of those, 55% were detected 6 times and 90% were detected multiple times (>2). In addition to the down-regulation of commonly reported proteins, such as lipocalin-1, lysozyme, and prolactin-inducible protein across all sub groups of DE, a number of proteins were significantly differentially regulated in MSDE and other subgroups of DE. A greater number of proteins were down-regulated in MSDE versus MDE, and the specific functions involved include response to stimulus (8 vs. 6 proteins), immune system process (6 vs. 4), regulation of biologic processes (3 vs. 3), and ion transport (2 vs. 2). CONCLUSIONS iTRAQ is one of the newest tools for quantitative mass spectrometry in tear proteome research. Differences in the protein ratios can be detected between normal and DE patients. PIR is a useful resource to interpret pathways and functions of proteins.
Collapse
Affiliation(s)
- Sruthi Srinivasan
- School of Optometry, University of Waterloo, Waterloo, Ontario, Canada
| | | | | | | | | |
Collapse
|
14
|
Zhou L, Beuerman RW. Tear analysis in ocular surface diseases. Prog Retin Eye Res 2012; 31:527-50. [PMID: 22732126 DOI: 10.1016/j.preteyeres.2012.06.002] [Citation(s) in RCA: 185] [Impact Index Per Article: 15.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2012] [Revised: 06/06/2012] [Accepted: 06/08/2012] [Indexed: 01/20/2023]
Abstract
The thin layer of tears covering the ocular surface are a complex body fluid containing thousands of molecules of varied form and function of several origins. In this review, we have discussed some key issues in the analysis of tears in the context of understanding and diagnosing eye disease using current technologies of proteomics and metabolomics, and for their potential for clinical application. In the last several years, advances in proteomics/metabolomics/lipidomics technologies have greatly expanded our knowledge of the chemical composition of tear fluid. The quickened pace of studies has shown that tears as a complex extra-cellular fluid of the ocular surface contains a great deal of molecular information useful for the diagnosis, prognosis, and treatment of ocular surface diseases that has the ability to addresses the emphasis on personalized medicine and biomarkers of disease. Future research directions will likely include (1) standardize tear collection, storage, extraction, and sample preparation; (2) quantitative proteomic analysis of tear proteins using multiple reaction monitoring (MRM)-based mass spectrometry; (3) population based studies of human tear proteomics/metabolomics; (4) tear proteomics/metabolomics for systemic diseases; and (5) functional studies of tear proteins.
Collapse
Affiliation(s)
- Lei Zhou
- Singapore Eye Research Institute, Singapore
| | | |
Collapse
|
15
|
You J, Hodge C, Wen L, McAvoy JW, Madigan MC, Sutton G. Using soybean trypsin inhibitor as an external loading control for Western blot analysis of tear proteins: application to corneal disease. Exp Eye Res 2012; 99:55-62. [PMID: 22498032 DOI: 10.1016/j.exer.2012.03.012] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2012] [Revised: 03/06/2012] [Accepted: 03/24/2012] [Indexed: 01/26/2023]
Affiliation(s)
- Jingjing You
- Save Sight Institute, Discipline of Ophthalmology, University of Sydney, GPO Box 4337, Sydney NSW 2001, Australia.
| | | | | | | | | | | |
Collapse
|
16
|
Green-Church KB, Butovich I, Willcox M, Borchman D, Paulsen F, Barabino S, Glasgow BJ. The international workshop on meibomian gland dysfunction: report of the subcommittee on tear film lipids and lipid-protein interactions in health and disease. Invest Ophthalmol Vis Sci 2011; 52:1979-93. [PMID: 21450916 DOI: 10.1167/iovs.10-6997d] [Citation(s) in RCA: 222] [Impact Index Per Article: 17.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Affiliation(s)
- Kari B Green-Church
- Department of Molecular and Cellular Biochemistry, Ohio State University, Columbus, Ohio 43210-1280, USA
| | | | | | | | | | | | | |
Collapse
|
17
|
Abstract
PURPOSE To determine the efficiency of several protein extraction or precipitation treatments used in proteomic analyses. METHODS Tear samples were taken from each eye of 40 normal subjects using glass microcapillaries. Tear volume was measured followed by storage at -86°C. Lotrafilcon B contact lenses were fitted and worn for 14 days, followed by removal and storage at -86°C. Tear samples from each eye within a subject were randomly assigned to either one of four chemical treatments (acetone, trichloroacetic acid, urea, and trifluoroacetic acid/acetonitrile [TFA/ACN]) or no chemical treatment in groups of 10. Contact lens samples were subjected to the same treatments as tear samples for each subject, with a second treatment preceding the first. Protein concentrations were quantified by Bradford assay. RESULTS For tear samples, a significant reduction in total protein was observed when subjected to any of the four treatments studied compared with those samples left untreated. A positive relationship was noted between protein concentration and tear volume for treated, untreated, and combined tear samples. For contact lens samples, there was a significant reduction in the amount of deposited protein removed when comparing acetone, trichloroacetic acid, and urea with TFA/ACN. A second extraction from contact lenses assigned to the urea and TFA/ACN groups yielded a significant amount of additional protein compared with the amount removed initially. CONCLUSIONS Tear samples subjected to any of the evaluated chemical treatments provided significantly less protein than untreated samples. For contact lenses, TFA/ACN extraction provided the highest yield of available protein out of the four treatments evaluated.
Collapse
|
18
|
Hatou S, Fukui M, Yatsui K, Mochizuki H, Akune Y, Yamada M. Biochemical analyses of lipids deposited on silicone hydrogel lenses. JOURNAL OF OPTOMETRY 2010; 3:164-168. [PMCID: PMC3974282 DOI: 10.1016/s1888-4296(10)70023-6] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/28/2010] [Accepted: 06/23/2010] [Indexed: 06/03/2023]
Abstract
Purpose This study was performed to determine the levels of lipids deposited on in vivo worn silicone hydrogel lenses. Methods Three silicone hydrogel materials, galyfilcon A, senofilcon A, and asmofilcon A, were worn for 2 weeks by 35 normal subjects. Total lipid deposition was determined by the sulfo-phospho-vanillin reaction. Cholesterol was estimated by a colorimetric probe through enzymatic oxidation. Phospholipid level was estimated by determining phosphorus with ammonium molybdate through enzymatic digestion. Results The total lipid content recovered from galyfilcon A, senofilcon A, and asmofilcon A was 32.9 ± 33.8, 42.1 ± 14.0, and 36.6 ± 31.9 μg/lens, respectively. The cholesterol content recovered from galyfilcon A, senofilcon A, and asmofilcon A was 26.2 ± 26.9, 28.6 ± 19.4, and 31.1 ± 21.1 μg/lens, respectively. There were no statistically significant differences in total lipids and cholesterol among the contact lens types. However, the quantity of phospholipid recovered from the asmofilcon A (7.0 ± 5.5 μg/lens) lenses was significantly higher than from galyfilcon A (1.1 ± 0.8 μg/lens) and senofilcon A (2.4 ± 0.8 mg/lens) lenses (p < 0.05, Mann-Whitney test). Conclusions The quantity of total lipid and cholesterol deposited on the 3 silicone hydrogel lenses tested did not differ. However, there were significant differences in the amounts of phospholipid deposited among the 3 silicone hydrogel lenses, of which clinical significance should be explored in the future study.
Collapse
Affiliation(s)
- Shin Hatou
- Division for Vision Research, National Institute of Sensory Organs, National Tokyo Medical Center, Tokyo, Japan
- Department of Ophthalmology, Keio University, School of Medicine, Tokyo, Japan
| | - Masaki Fukui
- Division for Vision Research, National Institute of Sensory Organs, National Tokyo Medical Center, Tokyo, Japan
| | - Keiichi Yatsui
- Division for Vision Research, National Institute of Sensory Organs, National Tokyo Medical Center, Tokyo, Japan
| | - Hiroshi Mochizuki
- Division for Vision Research, National Institute of Sensory Organs, National Tokyo Medical Center, Tokyo, Japan
| | - Yoko Akune
- Division for Vision Research, National Institute of Sensory Organs, National Tokyo Medical Center, Tokyo, Japan
| | - Masakazu Yamada
- Division for Vision Research, National Institute of Sensory Organs, National Tokyo Medical Center, Tokyo, Japan
| |
Collapse
|
19
|
You J, Fitzgerald A, Cozzi PJ, Zhao Z, Graham P, Russell PJ, Walsh BJ, Willcox M, Zhong L, Wasinger V, Li Y. Post-translation modification of proteins in tears. Electrophoresis 2010; 31:1853-61. [DOI: 10.1002/elps.200900755] [Citation(s) in RCA: 44] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
|
20
|
|